Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes

[1]  M. Borowiec,et al.  Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome , 2014, PloS one.

[2]  Darrell M. Wilson,et al.  Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia , 2014, Diabetes.

[3]  A. Pecheur,et al.  Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition , 2014, Journal of diabetes research.

[4]  B. Olsen,et al.  Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study , 2014, Acta Diabetologica.

[5]  M. Rewers,et al.  Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes , 2014, Diabetes Care.

[6]  L. Spano,et al.  Prognostic accuracy of continuous glucose monitoring in the prediction of diabetes mellitus in children with incidental hyperglycemia: receiver operating characteristic analysis. , 2013, Diabetes technology & therapeutics.

[7]  R. Beck,et al.  Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes , 2013, Diabetes Care.

[8]  M. Permutt,et al.  Early Brain Vulnerability in Wolfram Syndrome , 2012, PloS one.

[9]  L. Hooft,et al.  Continuous glucose monitoring systems for type 1 diabetes mellitus. , 2012, The Cochrane database of systematic reviews.

[10]  M. Borowiec,et al.  Wolfram syndrome in the Polish population: novel mutations and genotype–phenotype correlation , 2011, Clinical endocrinology.

[11]  G. Salzano,et al.  Diabetes and Neurodegeneration in Wolfram Syndrome , 2011, Diabetes Care.

[12]  M. Borowiec,et al.  Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene , 2011, Acta Diabetologica.

[13]  Wojciech Fendler,et al.  GlyCulator: A Glycemic Variability Calculation Tool for Continuous Glucose Monitoring Data , 2011, Journal of diabetes science and technology.

[14]  S. Powers,et al.  Use of continuous glucose monitoring in young children with type 1 diabetes: implications for behavioral research , 2011, Pediatric diabetes.

[15]  H Peter Chase,et al.  Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. , 2010, Diabetes technology & therapeutics.

[16]  A. Rigby,et al.  A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes , 2008, Diabetes Care.

[17]  B. Vialettes,et al.  Microvascular Diabetes Complications in Wolfram Syndrome (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness [DIDMOAD]) , 2007, Diabetes Care.

[18]  L. Jovanovic,et al.  Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values , 2006, Diabetes Care.

[19]  H. Aburatani,et al.  WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. , 2006, Human molecular genetics.

[20]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[21]  H. Katagiri,et al.  Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. , 2004, Human molecular genetics.

[22]  J. Loiselet,et al.  Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  D. D’Alessio,et al.  Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. , 2002, Diabetes.

[24]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[25]  A. Karasik,et al.  Genetically Programmed Selective Islet β-Cell Loss in Diabetic Subjects With Wolfram's Syndrome , 1989, Diabetes Care.

[26]  R. Ehrlich,et al.  Wolfram Syndrome: Report of Four New Cases and a Review of Literature , 1986, Diabetes Care.

[27]  M. Borowiec,et al.  The prevalence of Wolfram syndrome in a paediatric population with diabetes. , 2014, Endokrynologia Polska.

[28]  D. Megighian,et al.  Wolfram syndrome. , 2004, International journal of pediatric otorhinolaryngology.